ARCHIVES

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 41 | November 4, 2011

Download PDF Visit The Full Archive

Related Articles

Campus-Dweller Rabson Finds Comfort In NIH Security.

December 14, 2001

NCI Expects 200 CCP applications; Grand Rapids Workshop To Offer Last Chance to Ask Questions

September 24, 1982

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

NIH Financial Plan Slated For Discussion At Dec. 18 Meeting

December 14, 1990

NCI Clarifies P01 Grant Application Dates

September 13, 1996

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008